ClinicalTrials.gg
Drug

Rebamipide clinical trials

Also written Mucosta.

studies test it
38
open now
4
in phase 3
10
first study started
2004

How each study uses rebamipide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the rebamipide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Rebamipide
18
OPC-12759 Ophthalmic suspension
4
rebamipide 2% ophthalmic suspension
3
Rebamipide 2% ophthalmic solution
2
Rebamipide 1%
2

Brand

Mucosta
6

Development codes

OPC-12759
1

Studies by the year they started

38 studies that test it; most in 2009 (5)

Studies that test rebamipide, by start year
YearStudies
20043
20053
20073
20081
20095
20102
20112
20124
20131
20141
20151
20171
20192
20202
20222
20241
20251
20263

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
9
Phase 3
10
Phase 4
10
No phase
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 23 · Other 15

Otsuka Pharmaceutical Co., Ltd. (9) · Korea Otsuka Pharmaceutical Co., Ltd. (3) · Kubota Vision Inc. (3) · Samsung Medical Center (2) · Otsuka Pharmaceutical Development & Commercialization, Inc. (2) · Cairo University (2) · Pirogov Russian National Research Medical University (1) · Korea University Anam Hospital (1)

Often tested with

Tested in the same studies.

Pantoprazole (1) · Diquafosol (1) · Polaprezinc (1) · Celecoxib (1) · Mosapride (1) · Diosmin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test rebamipide.

Studies

Open first, then newest update. How each study uses rebamipide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 38

See all 38 studies that test rebamipide →

Given beside what is tested · 2 — rebamipide is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with rebamipide

Codes

What other systems call rebamipide · ClinicalTrials.gg INT003328

  • MeSH (NLM) C052785rebamipideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) LR583V32ZRREBAMIPIDEConfirmed FDA, NLM, Wikidata
  • Wikidata Q7301602rebamipideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29852RebamipideOne source FDA
  • DrugBank DB11656One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.